Madrigal Pharmaceuticals
MDGL
#2088
Rank
NZ$16.09 B
Marketcap
NZ$692.99
Share price
-4.45%
Change (1 day)
-30.25%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2026 (TTM): NZ-$10.22

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$10.80. In 2025 the company made an earnings per share (EPS) of NZ-$19.54 an increase over its 2024 EPS that were of NZ-$40.42.

EPS history for Madrigal Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$10.22-47.71%
2025NZ-$19.54-51.65%
2024NZ-$40.42
2022NZ-$31.5017.93%
2021NZ-$26.7111.61%
2020NZ-$23.93140.18%
2019NZ-$9.96146.61%
2018NZ-$4.04-12.99%
2017NZ-$4.64-91.03%
2016NZ-$51.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.35-96.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.74-83.93%๐Ÿ‡บ๐Ÿ‡ธ USA